This proposal is to study regulation and function of MAP kinase-activated protein kin ses (MAPKAPKs), which are important, expanding, and understudied components in the MAP kinase cascades. One key role of MAPKs is to control gene expression. MAPKs and MAPKAPKs collaborate in transcription, translation, and stabilization. Understanding this collaboration is vital to design of therapies in many diseases because MAP (mitogen-activated protein) kinase (MAPK) cascades are activated by extracellular signals (growth factors, hormones, cytokines) and intracellular signals (cellular stresses and checkpoints) as part of interconnected cascades of enzyme activations and inhibitions controlling metabolism, gene expression, and growth and development. Abnormal functions of the pathways is involved in cancer, proliferative complications of diabetes, and genetic disorders. There are three principal MAPKs (ERK, JNK, and p38 MAPK) but there are many isoforms. MAP kinases select specific targets for regulation, including members of a diverse group called collectively MAPKAPKs which extend the cascade. MAPKAPKs are related to each other by their C-terminal domains independent of whether they have one kinase domain (MNKs, MAPKAPK2) or two domains (RSKs, MSKs).
Aim one is determine how MAP kinases bind and regulate their specific MAPKAP kinase targets.
Aim two is to study the cellular functions of MAPKAPKs by surveying the mammalian proteome for phosphorylations inducible by MAPKAPKs.
Aim three is to design and use recombinant activated COOH-terminal domains (CTDS) of RSKs and MSKs to characterize their CTD kinase activity independently of the NTD domain, and to characterize nuclear RSKs and MSKs by extraction and chromatography.
Aim four is to characterize the activation, enzymatic properties, and functions of MAPKAP kinase-like enzymes (Rcklp, Rck2p) in yeast, a model eukaryote, using combined biochemical and genetic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM062890-03
Application #
6693812
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Anderson, Richard A
Project Start
2002-01-01
Project End
2005-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
3
Fiscal Year
2004
Total Cost
$279,720
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Sturgill, Thomas W; Stoddard, Paul B; Cohn, Steven M et al. (2010) The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors. Mol Cancer 9:104
Fu, Zheng; Kim, Jungeun; Vidrich, Alda et al. (2009) Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 297:G632-40
Rowlett, Robert M; Chrestensen, Carol A; Schroeder, Melanie J et al. (2008) Inhibition of tristetraprolin deadenylation by poly(A) binding protein. Am J Physiol Gastrointest Liver Physiol 295:G421-30
Rowlett, Robert M; Chrestensen, Carol A; Nyce, Mark et al. (2008) MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages. Am J Physiol Gastrointest Liver Physiol 294:G452-9
Chrestensen, Carol A; Eschenroeder, Andrew; Ross, William G et al. (2007) Loss of MNK function sensitizes fibroblasts to serum-withdrawal induced apoptosis. Genes Cells 12:1133-40
Chrestensen, Carol A; Shuman, Jacquelyn K; Eschenroeder, Andrew et al. (2007) MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J Biol Chem 282:4243-52
Martin, P M; Aeder, S E; Chrestensen, C A et al. (2007) Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta. Oncogene 26:407-14
Devasahayam, Gina; Burke, Daniel J; Sturgill, Thomas W (2007) Golgi manganese transport is required for rapamycin signaling in Saccharomyces cerevisiae. Genetics 177:231-8
Devasahayam, Gina; Ritz, Danilo; Helliwell, Stephen B et al. (2006) Pmr1, a Golgi Ca2+/Mn2+-ATPase, is a regulator of the target of rapamycin (TOR) signaling pathway in yeast. Proc Natl Acad Sci U S A 103:17840-5
Fu, Zheng; Larson, Katherine A; Chitta, Raghu K et al. (2006) Identification of yin-yang regulators and a phosphorylation consensus for male germ cell-associated kinase (MAK)-related kinase. Mol Cell Biol 26:8639-54

Showing the most recent 10 out of 15 publications